Home › Funds › Slate Path Capital LP › HUM
Slate Path Capital LP position in HUM
HUMANA INC · Health Care
Slate Path Capital LP reported holding 1,079,930 shares of HUM (HUMANA INC) in its Q2 2026 13F filing — a position valued at US$429.0M, representing 5.94% of its reported portfolio and ranking #4 among its reported holdings. Slate Path Capital LP has disclosed HUM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Slate Path Capital LP's HUM position evolved
Slate Path Capital LP first disclosed a stake in HUM in Q4 2025 at 953,000 shares (US$244.1M). The position peaked in Q2 2026 at 1,079,930 shares, worth US$429.0M. Across 3 filings, Slate Path Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,079,930 shares valued at US$429.0M — an increase of 620,230 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2026 (shares rose 130% over the following quarter), a 135% increase in Q2 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 953.00K | $244.09M | New |
| Q1 2026 | 459.70K | $79.71M | Reduce |
| Q2 2026 | 1.08M | $428.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HUM and 13F data
HUM (HUMANA INC) is a Health Care company. 32 other funds we track also report a position in HUM — the largest reported positions include Dodge & Cox (US$4.35B), DODGE & COX (US$4.35B), Pzena Investment Management (US$1.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HUM
- Dodge & Cox 10.94M sh · $4.35B · Q2 2026
- DODGE & COX 10.94M sh · $4.35B · Q2 2026
- Pzena Investment Management 4.40M sh · $1.75B · Q2 2026
- MFS Investment Management 3.58M sh · $1.66B · Q2 2026
- EAGLE CAPITAL MANAGEMENT LLC 3.85M sh · $1.53B · Q2 2026
- Sessa Capital IM, L.P. 3.73M sh · $1.48B · Q2 2026
- NAYA CAPITAL MANAGEMENT UK LTD 1.83M sh · $728.41M · Q2 2026
- Assenagon Asset Management S.A. 1.26M sh · $479.05M · Q3 2026
- Newport Trust Company, LLC 968.65K sh · $384.77M · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 878.38K sh · $348.91M · Q2 2026
More on Slate Path Capital LP
FAQ
How long has Slate Path Capital LP held HUM?
Slate Path Capital LP has disclosed HUM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Slate Path Capital LP's current position in HUM?
As of Q2 2026, Slate Path Capital LP holds 1.08M shares of HUM (HUMANA INC), valued at $428.97M, representing 5.94% of its reported portfolio and ranking #4.
Has Slate Path Capital LP been buying or selling HUM?
In the latest 13F filing (Q2 2026), Slate Path Capital LP increased its position in HUM. The position peaked in Q2 2026 at 1.08M shares.
Which other funds hold HUM?
Other major institutional holders of HUM include Dodge & Cox, DODGE & COX, Pzena Investment Management, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.